Interleukin-7 regulates CD127 expression and promotes CD8(+) T cell activity in patients with primary cutaneous melanoma

BACKGROUND: Interleukin (IL)-7 signaling through CD127 is impaired in lymphocytes in cancers and chronic infections, resulting in CD8(+) T cell exhaustion. The mechanisms underlying CD8(+) T cell responses to IL-7 in melanoma remain not completely elucidated. We previously showed reduced IL-7 level...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hongxia, Qiao, Binjun, Guo, Shuping, Cui, Hongzhou, Zhang, Ziyan, Qin, Junxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295418/
https://www.ncbi.nlm.nih.gov/pubmed/35850640
http://dx.doi.org/10.1186/s12865-022-00509-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295418/
https://www.ncbi.nlm.nih.gov/pubmed/35850640
http://dx.doi.org/10.1186/s12865-022-00509-0

Ejemplares similares